Yayın: Novel imidazo[2,1‐<i>b</i>]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation
| dc.contributor.author | Akalın‐Çiftçi, Gülşen | |
| dc.contributor.author | Nuray Ulusoy‐Güzeldemirci | |
| dc.contributor.author | Gülşen Akalın‐Çiftçi | |
| dc.contributor.author | Serap Çetinkaya | |
| dc.contributor.author | Abdulilah Ece | |
| dc.contributor.orcid | 0000-0002-4890-3124 | |
| dc.contributor.orcid | 0000-0001-7372-1704 | |
| dc.contributor.orcid | 0000-0002-3087-5145 | |
| dc.date.accessioned | 2025-11-13T09:38:50Z | |
| dc.date.issued | 2021-05-22 | |
| dc.identifier.doi | https://doi.org/10.1111/cbdd.13896 | |
| dc.identifier.endpage | 282 | |
| dc.identifier.issn | 1747-0277 | |
| dc.identifier.issue | 2 | |
| dc.identifier.openalex | W3162512295 | |
| dc.identifier.startpage | 270 | |
| dc.identifier.uri | https://hdl.handle.net/11421/1757 | |
| dc.identifier.uri | https://doi.org/10.1111/cbdd.13896 | |
| dc.identifier.volume | 98 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Chemical Biology & Drug Design | |
| dc.rights | restrictedAccess | |
| dc.subject | Thiazole | |
| dc.subject | Chemistry | |
| dc.subject | Focal adhesion | |
| dc.subject | Moiety | |
| dc.subject | In vitro | |
| dc.subject | Stereochemistry | |
| dc.subject | In silico | |
| dc.subject | Docking (animal) | |
| dc.subject | Kinase | |
| dc.subject | Cisplatin | |
| dc.subject | Biochemistry | |
| dc.subject | Combinatorial chemistry | |
| dc.subject | Signal transduction | |
| dc.subject | Biology | |
| dc.subject.sdg | 3 | |
| dc.title | Novel imidazo[2,1‐<i>b</i>]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5068969402 |
